NCT05501041
Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid
Enrolling by Invitation
Not specifiedAges 18+ObservationalMayo ClinicInvestigator-initiated
~300 participants
Updated 2025-09-15 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in symptoms before and after ablation
Measured over Baseline and 1-, 3-, 6-, 12-, 18-, and 24-months following treatment
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Thomas Atwell, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Change in symptoms before and after ablationBaseline and 1-, 3-, 6-, 12-, 18-, and 24-months following treatment
Measured using a modified 6-item SYS questionnaire that objectively measures patient symptoms on a scale of 0=none, 1=moderate, 2=severe